G-CSF in the Treatment of Acute Myeloid Leukemia: Is it safe?

References

• Groopman J. E., Molina JM., Scadden D. T. Hematopoietic growth factors: Biology and clinical applications. N. Engl. J. Med. 1989; 321: 1449–1459
   PubMed Web of Science ®Google Scholar
• Antman K. S., Griffin J. D., Elias A., et al. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. N. Engl. J. Med. 1988; 319: 593–598
   PubMed Web of Science ®Google Scholar
• Sheridan W. P., Morstyn G., Wolf M., et al. Gran-ulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet 1989; 2: 891–895
   PubMed Web of Science ®Google Scholar
• Souza L. M., Boone T. C., Gabrilove J. L., et al. Recombinant human granulocyte colony-stimulating factor: Effects on normal and leukemic myeloid cells. Science 1986; 232: 61–65
   PubMed Web of Science ®Google Scholar
• Griffin J. D., Lowenberg B. Clonogenic cells in acute myeloblastic leukemia. Blood 1986; 68: 1185–1195
   PubMed Web of Science ®Google Scholar
• Vellenga E., Young D. C., Wagner K., et al. The effect of GM-CSF and G-CSF in promoting growth of clonogenic cells in acute myeloblastic leukemia. Blood 1987; 69: 1771–1776
   PubMed Web of Science ®Google Scholar
• Vellenga E., Ostapovicz D., O'Rourke B., Griffin J. D. Effects of recombinant IL-3, GM-CSF, and G-CSF on proliferation of leukemic clonogenic cells in short-term and long-term cultures. Leukemia 1987; 1: 584–589
   PubMed Web of Science ®Google Scholar
• Asano Y., Okamura S., Shibuya T., Harada M., Niho Y. Growth of clonogenic myeloblastic leukemic cells in the presence of human recombinant erythropoietin in addition to various human recombinant hematopoietic growth factors. Blood 1988; 72: 1682–1686
   PubMed Web of Science ®Google Scholar
• Delwel R., Salem M., Pellens C., Dorssers L., Wage-Maker G., Clark S., Lowenberg B. Growth regulation of human acute myeloid leukemia: Effects of five recombinant hematopoietic factors in a serum-free culture system. Blood 1988; 72: 1944–1949
   PubMed Web of Science ®Google Scholar
• Lowenberg B., Salem M., Delwel R. Effects of recombinant multi-CSF, GM-CSF, G-CSG and M-CSF on the proliferation and maturation of human AML in vitro. Blood Cells 1988; 14: 539–549
   PubMedGoogle Scholar
• Motoji T., Takanashi M., Fuchinoue M., Masuda M., Oshimi K., Mizoguchi H. Effect of recombinant GM-CSF and recombinant G-CSF on colony formation of blast progenitors in acute myeloblastic leukemia. Exp. Hematol. 1989; 17: 56–60
   PubMed Web of Science ®Google Scholar
• Park L. S., Waldron P. E., Friend D., et al. Inter-leukin-3, GM-CSF, and G-CSF receptor expression on cell lines and primary leukemia cells: receptor heterogeneity and relationship to growth factor responsiveness. Blood 1989; 74: 56–65
   PubMed Web of Science ®Google Scholar
• Motoji T., Takanashi M., Masuda M., Nakayama K., Oshimi K., Mizoguchi H. Colony stimulating activities of GM-CSF, G-CSF and IL-3 on blast progenitors from acute myeloblastic leukemia. Leukemia and Lymphoma 1990; 2: 407–414
   PubMed Web of Science ®Google Scholar
• Inoue C., Hotta T., Murate T., Saito H. Response of leukemic cells to the sequential combination of GM-CSF and G-CSF. Int. J. Cell. Biol. 1990; 8: 54–62
   Google Scholar
• Lemoli R. M., Gulati S. C., Strife A., Lambek C., Perez A., Clarkson B. D. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination. Leukemia 1991; 5: 386–391
   PubMed Web of Science ®Google Scholar
• Budel L. M., Touw I. P., Delwel R., Lowenberg B. Granulocyte colony-stimulating factor receptors in human acute myelocytic leukemia. Blood 1989; 74: 2668–2673
   PubMed Web of Science ®Google Scholar
• Motoji T., Watanabe M., Uzumaki H., et al. Granulocyte colony-stimulating factor (G-CSF) receptors on acute myeloblastic leukaemia cells and their relationship with the proliferative response to G-CSF in clonogenic assay. Br. J. Haematol. 1991; 77: 54–59
   PubMed Web of Science ®Google Scholar
• Watanabe M., Fukamachi H., Uzumaki H., et al. Mutant protein of recombinant human granulocyte colony-stimulating factor for receptor binding assay. Analyt. Biochem. 1991; 195: 1–7
   PubMed Web of Science ®Google Scholar
• Colombo M. P., Ferrari G., Stoppacciaro A., et al. Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo. J. Exp. Med. 1991; 173: 889–897
   PubMed Web of Science ®Google Scholar
• Ohno R., Tomonaga M., Kobayashi T., et al. Effect of granulocyte colony stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia: A randomized controlled study. N. Engl. J. Med. 1990; 323: 871–877
   PubMed Web of Science ®Google Scholar
• Masaoka T., Moriyama Y., Kato S., et al. A double-blind controlled study of KRN 8601 (rhG-CSF) in patients received allogeneic bone marrow transplantation. Kyo-no-Is-hoku 1990; 3: 233–239
   Google Scholar
• Asano S., Masaoka T., Takaku F., Ogawa N. Placebo controlled double-blind trial of recombinant human granulocyte colony-stimulating factor for bone marrow transplantation. Kyo-no-Ishoku 1990; 3: 317–321
   Google Scholar
• Ohno R., Masaoka T., Asano S., Takaku F. G-CSF after intensive induction chemotherapy in refractory acute leukemia and bone marrow transplantation in myeloid leukemia. Haematol. Blood Transf. 1992; 34: 101–107
   Google Scholar
• Ohno R., Kobayashi T., Tanimoto M., et al. Randomized study of individualized induction therapy with or without vincristine, and of maintenance/intensification therapy between 4 or 12 courses in acute myeloid leukemia of adults; Japan Adult Leukemia Study Group AML-87 Study. Cancer 1993; 71: 3888–3895
   PubMed Web of Science ®Google Scholar
• Ohno R., Hiraoka A., Tanimoto M., et al. No increase of leukemia relapse in newly diagnosed patients with acute myeloid leukemia who received G-CSF after remission induction or consolidation therapy. Blood 1993; 81: 561–562
   PubMed Web of Science ®Google Scholar
• Ohno R., Kanamaru A., Yoshida Y., et al. A double-blind controlled study on G-CSF started from two days prior to induction chemotherapy in refractory acute myeloid leukemia (in preparation)
   Google Scholar